Skip to main content
Clinical Trials/ACTRN12613001148763
ACTRN12613001148763
Not yet recruiting
Phase 3

Comparison of Fluticasone and Budesonide Intranasal Corticosteroid in Terms of Taste, Sensation, Delivery and Adherence in Children Aged 6-14 Years with allergic rhinitis (Hayfever)

Mater Health Services0 sites110 target enrollmentOctober 15, 2013

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Allergic rhinitis
Sponsor
Mater Health Services
Enrollment
110
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 15, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mater Health Services

Eligibility Criteria

Inclusion Criteria

  • 1\.Children aged 6\-14 years.
  • 2\.Symptoms of perennial allergic rhinitis which following clinician assessment is felt to warrant treatment (persistent or moderate to severe intermittent allergic rhinitis).
  • 3\. Not currently using a nasal corticosteroid.

Exclusion Criteria

  • 1\. Hypersensitivity or intolerance to steroids.
  • 2\. Currently using or having used an inhaled corticosteroid in the previous month.
  • 3\. Currently taking Montelukast.
  • 4\. No sense of smell.
  • 5\. Receiving immunotherapy.
  • 6\. Epistaxis in the previous week.
  • 7\. Evidence of broken skin involving the nasal mucosa.

Outcomes

Primary Outcomes

Not specified

Similar Trials